| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6189895 | Bulletin du Cancer | 2016 | 9 Pages |
Abstract
The perceptual gap between clinicians and patients regarding the incidence and impact of CINV/RINV contributes to a sub-optimal level of anti-emetic cover and control. The anti-emetic regimen needs to be regularly assessed and adapted to the patient in order to improve CINV/RINV management.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Sophie Morin, Irina Leurs, Marie-Noëlle Bousquet, Florian Scotté,